Trademark: 87784846
Word
ONESOURCE
Status
Registered
Status Code
700
Status Date
Tuesday, April 5, 2022
Serial Number
87784846
Registration Number
6688750
Registration Date
Tuesday, April 5, 2022
Mark Type
4000
Filing Date
Monday, February 5, 2018
Published for Opposition
Tuesday, August 11, 2020

Trademark Owner History

Classifications
41 Training services, namely, business training advisory and consultancy services relating to the use, handling, optimization, calibration, and maintenance of laboratory equipment and related software; educational services, namely, conducting technical discussion meetings and technical training seminars on topics of business, administration operation, regulatory and standards compliance, and management of scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories, experimental testing and analysis, data management, and quality assurance
37 Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of laboratory instruments for scientific, pharmaceutical, and medical research, analysis, and diagnostic use; Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of computer hardware for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Laboratory equipment installation for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories
35 Relocation services for businesses, namely, laboratories; relocation services for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories, namely, inventory recordation and equipment labeling in the nature of inventory management and transportation logistics, namely, arranging the transportation of goods for others; services in the nature of arranging transportation of specimens, chemicals, and samples for others; business management consulting services, namely, laboratory application efficiency and method consulting and design for scientific research and medical analytical and diagnostic laboratories in the nature of identification of customer objectives and goals and providing strategic recommendations; business management consulting services, namely, research, analysis, and reporting in the field of workflow, productivity analysis, and personnel management in scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories for business purposes; consulting services, namely, providing business information and business management advice to others for maintaining, optimizing, and extending the lifecycle and productivity of analytical and diagnostic laboratory equipment; business management consulting services in the field of purchases, namely, assisting laboratories with the purchase of scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments; business management consulting services in the field of science and technology, namely, assisting laboratories with identifying scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments for purchase; employment staffing services, namely, filling the temporary staffing needs of scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories; benchmarking services for scientific, medical, and pharmaceutical research and diagnostic laboratories and equipment, namely, analyzing and providing business strategic planning feedback regarding performance efficiency, usage and throughput, regulatory compliance, and quality standards; information technology support services in the nature of asset management and risk mitigation, namely, reporting on service histories, utilization of the medical assets, end of product life information and replacement costs all related to medical diagnostic, clinical and biomedical equipment
44 Laboratory Medical services in the nature of medical analysis and diagnosis, excluding analysis and diagnosis at the point of patient care; genetic analysis and reporting services for medical purposes; nucleic acid sequencing and analysis services for medical purposes; genome sequencing and analysis services for medical purposes; DNA screening for medical purposes; consultation in the field of medicine, health and pharmaceuticals, excluding consultation at the point of patient care and in pharmacies; DNA and polynucleic acid testing services being medical diagnostic services; conducting medical tests to diagnose disease
42 Data services, namely, data integrity governance, data management, data reporting, data monitoring, data translation, data transformation, data storage, data analytics, and data integration for data generated in scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories; computer support services for laboratories, namely, providing information technology technical support performed by science-knowledgeable professionals, and electronic monitoring of data from laboratory instruments for quality control purposes; information technology services in the nature of planning, designing, implementing, deploying, installing, customizing, integrating, managing, migrating, testing, validating, and supporting of scientific and laboratory informatics data systems, applications, processes, and technologies; analytics services in the nature of implementation and management of web portals, mobile applications, interactive dashboards, connected instrument utilization, RFID powered asset location, predictive maintenance, and data-driven prescriptive recommendations in the fields of scientific, pharmaceutical, and medical research and diagnostic laboratories; remote technical and diagnostic support in the nature of monitoring technological functions of laboratory instruments for scientific, medical, and pharmaceutical research and diagnostics use; remote technical and diagnostic support in the nature of monitoring technological functions of computer hardware for scientific, research, medical, and diagnostics use; technology testing, inspection, evaluation, verification, analysis and development of laboratory equipment and protocols to verify compliance with regulatory, quality, quantity, consistency, performance, ethical or safety standards; computational chemistry services in the nature of biological research for identification, design, optimization, and study of biologics; research in the fields of science, technology, medicine and health, namely, tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization, for others for use in life science research and biotechnology research; consultation services in the field of science and technology, namely, consultation in the field of cell and tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, and scientific efficiencies and productivity, for use in life science research and biotechnology research; medical laboratory, pharmaceutical research and laboratory diagnostic services in the field of DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization for others for use in life science research and biotechnology research; laboratory support services, namely, cell and tissue culture maintenance and harvest, preparation of cell and tissue media, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, implementation of scientific efficiencies and productivity for others for use in life science research and biotechnology research, and daily equipment start-up and shut down; planning and layout design services for laboratories; consulting services in the field of laboratory automation; Installation, maintenance, optimization, repair, and refurbishment of computer software for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Pre-move testing of laboratory equipment and post-move laboratory equipment testing and calibration for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories

Trademark Events
Jun 21, 2023
Teas Change Of Correspondence Received
Jun 21, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 21, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 21, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 21, 2023
Teas Change Of Owner Address Received
Mar 29, 2023
Automatic Update Of Assignment Of Ownership
Apr 5, 2022
Registered-Principal Register
Mar 22, 2021
Changes/Corrections After Pub Approval Entered
Mar 17, 2021
Assigned To Petition Staff
Jan 13, 2021
Extension Of Time To Oppose Process - Terminated
Dec 8, 2020
Teas Post Publication Amendment Received
Sep 10, 2020
Extension Of Time To Oppose Received
Aug 11, 2020
Official Gazette Publication Confirmation E-Mailed
Aug 11, 2020
Published For Opposition
Jul 22, 2020
Notification Of Notice Of Publication E-Mailed
Jul 8, 2020
Law Office Publication Review Completed
Jun 26, 2020
Approved For Pub - Principal Register
Jun 26, 2020
Examiner's Amendment Entered
Jun 26, 2020
Notification Of Examiners Amendment E-Mailed
Jun 26, 2020
Examiners Amendment E-Mailed
Jun 26, 2020
Examiners Amendment -Written
Jun 8, 2020
Assigned To Examiner
Jun 4, 2020
Assigned To Examiner
Apr 22, 2020
Teas/Email Correspondence Entered
Apr 21, 2020
Correspondence Received In Law Office
Apr 21, 2020
Teas Response To Office Action Received
Nov 25, 2019
Notification Of Non-Final Action E-Mailed
Nov 25, 2019
Non-Final Action E-Mailed
Nov 25, 2019
Non-Final Action Written
Nov 20, 2019
Previous Allowance Count Withdrawn
Nov 12, 2019
Withdrawn From Pub - Og Review Query
Oct 28, 2019
Law Office Publication Review Completed
Oct 24, 2019
Assigned To Lie
Oct 22, 2019
Approved For Pub - Principal Register
Oct 22, 2019
Examiner's Amendment Entered
Oct 22, 2019
Notification Of Examiners Amendment E-Mailed
Oct 22, 2019
Examiners Amendment E-Mailed
Oct 22, 2019
Examiners Amendment -Written
Oct 1, 2019
Teas/Email Correspondence Entered
Sep 30, 2019
Correspondence Received In Law Office
Sep 30, 2019
Teas Response To Office Action Received
Apr 1, 2019
Notification Of Non-Final Action E-Mailed
Apr 1, 2019
Non-Final Action E-Mailed
Apr 1, 2019
Non-Final Action Written
Jan 14, 2019
Notification Of Non-Final Action E-Mailed
Jan 14, 2019
Non-Final Action E-Mailed
Jan 14, 2019
Non-Final Action Written
Jan 14, 2019
Previous Allowance Count Withdrawn
Jan 7, 2019
Jurisdiction Restored To Examining Attorney
Dec 18, 2018
Withdrawn From Issue - Senior Attorney Request
Dec 18, 2018
Official Gazette Publication Confirmation E-Mailed
Dec 18, 2018
Published For Opposition
Nov 28, 2018
Notification Of Notice Of Publication E-Mailed
Nov 7, 2018
Assigned To Lie
Oct 24, 2018
Approved For Pub - Principal Register
Oct 24, 2018
Examiner's Amendment Entered
Oct 24, 2018
Notification Of Examiners Amendment E-Mailed
Oct 24, 2018
Examiners Amendment E-Mailed
Oct 24, 2018
Examiners Amendment -Written
Oct 11, 2018
Notification Of Final Refusal Emailed
Oct 11, 2018
Final Refusal E-Mailed
Oct 11, 2018
Final Refusal Written
Aug 21, 2018
Teas/Email Correspondence Entered
Aug 20, 2018
Correspondence Received In Law Office
Aug 20, 2018
Teas Response To Office Action Received
Mar 15, 2018
Notification Of Non-Final Action E-Mailed
Mar 15, 2018
Non-Final Action E-Mailed
Mar 15, 2018
Non-Final Action Written
Mar 6, 2018
Assigned To Examiner
Feb 13, 2018
New Application Office Supplied Data Entered
Feb 8, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24